• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎克雷伯菌脂质体包裹脂多糖抗原在大鼠大叶性肺炎模型中的保护作用

Protective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumonia.

作者信息

Chhibber Sanjay, Wadhwa Sunita, Yadav Vanashree

机构信息

Department of Microbiology, Panjab University, Chandigarh 160014, India.

出版信息

Jpn J Infect Dis. 2004 Aug;57(4):150-5.

PMID:15329446
Abstract

In a lobar pneumonia model of Klebsiella pneumoniae, the immunoprotective role of free lipoploysaccharide (LPS) and liposome-incorporated LPS was studied. An alteration in the biological activity of the LPS molecule, in terms of its pyrogenicity and lethal toxicity, was observed on incorporation in the liposome. Compared at equal doses, liposome-incorporated LPS was found to be non-pyrogenic and 10 times less toxic than free LPS. Liposome-incorporated LPS was more effective in providing protection against K. pneumoniae induced lobar pneumonia in rats. The immunological mechanism underlying protection revealed involvement of both nonspecific and specific immune response. Alveolar macrophage activation was observed after 4 and 14 days of treatment with the free and liposome-entrapped forms of LPS, respectively. Specific immunity in terms of plaque-forming cells was seen with both forms of LPS. Delayed type hypersensitivity reaction was observed only with liposome-incorporated LPS. It is concluded that a non-toxic and immunogenic form of K. pneumoniae LPS can be obtained by incorporation of the native preparation into liposomes.

摘要

在肺炎克雷伯菌的大叶性肺炎模型中,研究了游离脂多糖(LPS)和脂质体包裹的LPS的免疫保护作用。当LPS分子掺入脂质体时,观察到其热原性和致死毒性方面的生物活性发生了改变。在相同剂量下比较发现,脂质体包裹的LPS无热原性,毒性比游离LPS低10倍。脂质体包裹的LPS在为大鼠提供针对肺炎克雷伯菌诱导的大叶性肺炎的保护方面更有效。保护作用的免疫机制显示非特异性和特异性免疫反应均参与其中。分别在用游离和脂质体包裹形式的LPS处理4天和14天后观察到肺泡巨噬细胞活化。两种形式的LPS均可见到形成噬斑细胞方面的特异性免疫。仅脂质体包裹LPS观察到迟发型超敏反应。结论是,通过将天然制剂掺入脂质体中可获得无毒且具有免疫原性的肺炎克雷伯菌LPS形式。

相似文献

1
Protective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumonia.肺炎克雷伯菌脂质体包裹脂多糖抗原在大鼠大叶性肺炎模型中的保护作用
Jpn J Infect Dis. 2004 Aug;57(4):150-5.
2
Immunoprotective potential of polysaccharide-tetanus toxoid conjugate in Klebsiella pneumoniae induced lobar pneumonia in rats.多糖-破伤风类毒素偶联物对大鼠肺炎克雷伯菌诱导的大叶性肺炎的免疫保护潜力。
Indian J Exp Biol. 2005 Jan;43(1):40-5.
3
Protection against Klebsiella pneumoniae induced lobar pneumonia in rats with lipopolysaccharide and related antigens.脂多糖及相关抗原对大鼠肺炎克雷伯菌诱导的大叶性肺炎的保护作用。
Can J Microbiol. 1990 Dec;36(12):885-90. doi: 10.1139/m90-153.
4
Polysaccharide-iron-regulated cell surface protein conjugate vaccine: its role in protection against Klebsiella pneumoniae-induced lobar pneumonia.多糖-铁调节的细胞表面蛋白结合疫苗:其在预防肺炎克雷伯菌引起的大叶性肺炎中的作用。
Vaccine. 1995 Feb;13(2):179-84. doi: 10.1016/0264-410x(95)93133-t.
5
Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.靶向包膜下抗原以预防肺炎克雷伯菌感染。
Vaccine. 2008 Oct 16;26(44):5649-53. doi: 10.1016/j.vaccine.2008.07.100. Epub 2008 Aug 24.
6
Lipopolysaccharide O-antigen promotes persistent murine bacteremia.脂多糖O抗原促进小鼠持续性菌血症。
Shock. 2007 Feb;27(2):186-91. doi: 10.1097/01.shk.0000238058.23837.21.
7
LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia.缺乏脂多糖结合蛋白的小鼠对革兰氏阴性菌引起的肺炎防御能力受损,但对革兰氏阳性菌引起的肺炎防御不受影响。
Int Immunol. 2004 Nov;16(11):1605-11. doi: 10.1093/intimm/dxh161. Epub 2004 Sep 27.
8
Lipopolysaccharide-mediated protection against Klebsiella pneumoniae-induced lobar pneumonia: intranasal vs. intramuscular route of immunization.脂多糖介导的针对肺炎克雷伯菌诱导的大叶性肺炎的保护作用:经鼻与肌肉注射免疫途径
Folia Microbiol (Praha). 2005;50(1):83-6. doi: 10.1007/BF02931298.
9
Alginate microparticles loaded with lipopolysaccharide subunit antigen for mucosal vaccination against Klebsiella pneumoniae.负载脂多糖亚基抗原的藻酸盐微粒用于肺炎克雷伯菌的黏膜疫苗接种
Biologicals. 2015 May;43(3):195-201. doi: 10.1016/j.biologicals.2015.02.001. Epub 2015 Feb 28.
10
Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.脂质体包裹庆大霉素对大鼠肺炎克雷伯菌肺炎的治疗效果与宿主防御功能受损及细菌对庆大霉素低敏感性的关系
Antimicrob Agents Chemother. 2001 Feb;45(2):464-70. doi: 10.1128/AAC.45.2.464-470.2001.

引用本文的文献

1
Exploring current hypervirulent infections: insights into pathogenesis, drug resistance, and vaccine prospects.探索当前的高毒力感染:对发病机制、耐药性及疫苗前景的见解
Front Microbiol. 2025 May 29;16:1604763. doi: 10.3389/fmicb.2025.1604763. eCollection 2025.
2
Lipopolysaccharide as a Vaccine Target and the Role of Antibodies in Protection from Disease.脂多糖作为疫苗靶点及抗体在预防疾病中的作用。
Vaccines (Basel). 2024 Oct 17;12(10):1177. doi: 10.3390/vaccines12101177.
3
Animal models of mucosal infections.黏膜感染的动物模型。
Front Microbiol. 2024 Mar 15;15:1367422. doi: 10.3389/fmicb.2024.1367422. eCollection 2024.
4
Prophylactic vaccine delivery systems against epidemic infectious diseases.针对流行性传染病的预防性疫苗投递系统。
Adv Drug Deliv Rev. 2021 Sep;176:113867. doi: 10.1016/j.addr.2021.113867. Epub 2021 Jul 17.
5
From Colonization to Dissemination: An Overview of Studies Implementing Murine Models.从定植到播散:实施小鼠模型研究的概述
Microorganisms. 2021 Jun 12;9(6):1282. doi: 10.3390/microorganisms9061282.
6
Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host.在普通大肠杆菌宿主中生产针对肺炎克雷伯菌 O2 血清型的有前途的生物合成自组装纳米缀合物疫苗。
Adv Sci (Weinh). 2021 Jul;8(14):e2100549. doi: 10.1002/advs.202100549. Epub 2021 May 24.
7
Prophylaxis and Treatment against : Current Insights on This Emerging Anti-Microbial Resistant Global Threat.预防和治疗:对抗这种新兴的抗微生物耐药性全球威胁的最新见解。
Int J Mol Sci. 2021 Apr 14;22(8):4042. doi: 10.3390/ijms22084042.
8
Progress towards the development of Klebsiella vaccines.迈向开发肺炎克雷伯菌疫苗的进展。
Expert Rev Vaccines. 2019 Jul;18(7):681-691. doi: 10.1080/14760584.2019.1635460. Epub 2019 Jun 28.
9
Potential targets for next generation antimicrobial glycoconjugate vaccines.新一代抗菌糖缀合物疫苗的潜在靶标。
FEMS Microbiol Rev. 2018 May 1;42(3):388-423. doi: 10.1093/femsre/fuy011.
10
Development of a new trend conjugate vaccine for the prevention of Klebsiella pneumoniae.开发一种用于预防肺炎克雷伯菌的新型趋势结合疫苗。
Infect Dis Rep. 2012 Jul 23;4(2):e33. doi: 10.4081/idr.2012.e33. eCollection 2012 Apr 27.